Ocular Therapeutix (OCUL) Inventory Average (2014 - 2026)
Ocular Therapeutix (OCUL) recorded quarterly Inventory Average of $3.7 million in Q1 2026, up 3.53% quarter-over-quarter from $3.5 million in Q4 2025, and up 15.72% on a YoY basis from $3.2 million in Q1 2025.
Ocular Therapeutix (OCUL) Inventory Average (2014 - 2026) Analysis & Trends
Ocular Therapeutix's Inventory Average history runs 13 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- In Q1 2026, Inventory Average rose 15.72% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 15.72% YoY), while the FY2025 annual figure was $3.3 million, up 23.55% from the prior year.
- Inventory Average was $3.7 million for Q1 2026 at Ocular Therapeutix, up from $3.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $3.7 million in Q1 2026 to a low of $1.3 million in Q1 2022.
- Historically, Inventory Average has averaged $2.5 million across 5 years, with a median of $2.4 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Inventory Average surged 62.58% in 2023, then grew 11.01% in 2024.
- A 5-year view of Inventory Average shows it stood at $1.8 million in 2022, then climbed by 29.64% to $2.3 million in 2023, then grew by 19.36% to $2.7 million in 2024, then advanced by 29.51% to $3.5 million in 2025, then climbed by 3.53% to $3.7 million in 2026.
- The last three Inventory Average figures came in at $3.7 million (Q1 2026), $3.5 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn | 3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 1.12 Mn |